Big Pharma In The Crypto Game: $60M Investment For BNB Treasury Strategy

17.07.25 15:00 Uhr

Werte in diesem Artikel
Aktien

344,90 EUR -5,30 EUR -1,51%

Indizes

23.272,3 PKT 52,4 PKT 0,23%

21.108,3 PKT 50,4 PKT 0,24%

Windtree Therapeutics (WINT), a biotech company dedicated to developing therapies for critical health conditions, has announced a significant partnership with Build and Build Corporation. The two companies revealed a $200 million securities purchase agreement aimed at establishing a Binance Coin (BNB) treasury.First NASDAQ-Listed Company Offering Direct BNB ExposureUnder the terms of this agreement, Windtree has the potential to secure an additional $140 million in gross proceeds through future subscriptions, which would bring total subscriptions to $200 million. The funds—expected to come in the form of cash, shares of Osprey BNB Chain Trust, and BNB tokens—will primarily be utilized to implement a BNB crypto treasury strategy. This, according to the firm’s official announcement, positions Windtree as a pioneer in the BNB digital asset space, aiming to be the first NASDAQ-listed company to provide direct exposure to the BNB token, which currently ranks as the fifth-largest blockchain by market capitalization.The initiative reportedly addresses a pressing need for both retail and institutional investors seeking regulated access to the Binance ecosystem, one of the leading ecosystems in the digital asset industry.The Most Liquid Crypto Exchange Token? The firm also praised the Binance ecosystem, anchored by one of the world’s largest cryptocurrency exchanges. Windtree also considered the growing metrics of the token, noting that BNB boasts average daily trading volumes exceeding $2 billion, making it the largest and most liquid crypto exchange token globally.Patrick Horsman, CFA and Director of Build & Build Corp, expressed enthusiasm about the partnership, stating:We are thrilled to propose a groundbreaking BNB strategy to the US market. This innovative solution will offer investors targeted exposure to Binance and BNB, addressing what we believe to be a critical gap in the US investment landscape.The Binance Smart Chain supports swift, low-cost transactions and fosters a thriving decentralized finance (DeFi) ecosystem that includes thousands of decentralized applications (dApps) and millions of users. With a dominant market share in Asia, Windtree asserts that Binance and its ecosystem are poised for significant growth in both global and US markets. Jed Latkin, Chief Executive Officer of Windtree, emphasized the importance of this transaction, noting:Today marks a pivotal moment for Windtree. This transaction secures up to $200 million from institutional investors, offering our shareholders a unique opportunity to gain exposure to a BNB-focused crypto treasury strategy.At the time of writing, Binance Coin is trading at $717, having registered significant gains of 9% and 10% over the past fourteen days and one month, respectively. Despite this recovery, the token is still trading 8.6% below its record price of $788, which was reached during last December’s rally.Featured image from DALL-E, chart from TradingView.comWeiter zum vollständigen Artikel bei NewsBTC

In eigener Sache

Übrigens: Strategy (ex MicroStrategy) und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Strategy (ex MicroStrategy)

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Strategy (ex MicroStrategy)

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: NewsBTC

Nachrichten zu Strategy (ex MicroStrategy)

Wer­bung

Analysen zu Strategy (ex MicroStrategy)

DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
28.07.2017Microstrategy A HoldDeutsche Bank AG
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
11.12.2015Microstrateg a BuyMizuho
DatumRatingAnalyst
28.07.2017Microstrategy A HoldDeutsche Bank AG
19.10.2015Microstrateg a HoldLake Street
31.10.2012Microstrateg a neutralROTH Capital Partners, LLC
30.10.2012Microstrateg a neutralUBS AG
31.07.2012Microstrateg a neutralUBS AG
DatumRatingAnalyst
16.03.2005Update Microstrategy Inc.: SellWedbush Morgan
09.02.2005Update Microstrategy Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Strategy (ex MicroStrategy) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen